ADVISORY
New updates in the Philippine National Formulary as of 03 August 2022

Change in the Generic Name of Nicotine Polacrilex Medicated Chewing Gum to Nicotine pursuant to DC No. 2022-0400

You may view the updates at PNF Section
Strategic Framework and Implementing Guidelines of the Philippine Medicines Policy 2022-2030
DOH Showcased “Malasakit at Aksyon” in the 1st face to face Policy Dialogue Since 2019
Program implementation review and updates on the different programs of the pharmaceutical division
Duterte Legacy Summit highlights DOH efforts on setting Maximum Retail Price for high-cost medicines
1st Hybrid Workshop on the Development of Guidelines in the Creation of the Philippine Essential Medical Devices List (PEMDL)

Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.

//
August 2, 2022

After three long years and five virtual policy dialogues, the Department of Health (DOH), its partner agencies and offices and the patient support groups and civil society organizations finally convened again face to face during the 16th Policy Dialogue on Universal Healthcare and Access to Medicines held on June 9, 2022 at Cocoon Boutique Hotel, Quezon City.

//
June 10, 2022

The Department of Health-Pharmaceutical Division (DOH-PD) conducted a face-to-face Program Implementation Review (PIR) and updates on the different programs of the Pharmaceutical Division in Coron Palawan last April 26-28, 2022 after two years of restrictions from the COVID-19 pandemic.

//
June 1, 2022

The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.

//
June 1, 2022

A successful initial collaboration of the DOH Pharamceutical Division – Medical Device Unit spearheaded by Dir. Anna Melissa S. Guerrero, MD, MPH (HTA) and Dr. Constante Caluya III, MBA and their Expert Advisory Committee for medical devices and supplies led by Dr. Ronaldo H. Estacio, together with the Health Technology Assessment Division headed by Ms. Anne Julienne Genuino-Marfori, RPh, MSc and their Health Technology Assessment Council chaired by Dr. Marita V. Tolentino-Reyes.

//
May 20, 2022

Philippine Generics summit celebration 2022

0 Days
0 Hours
0 Minutes
0 Seconds

Advisories

DOH updates list of VAT-Exempt Medicines under RA 11354

The Department of Health (DOH) informed the Bureau of Internal Revenue (BIR) through Commissioner Caesar R. Dulay the revisions to the list of VAT-Exempt Medicines under Republic Act. 11354 or Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.

Read More »

Events

Philippine Standard time

Contact Us:

Telephone Number: 02-8757734 Loc. 253

Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City

Email Address: pharmareceiving@doh.gov.ph